NCT01847131View on ClinicalTrials.gov

Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Nasal Obstruction Present Finding
Interventions
DRUG

oxymetazoline

0.05% Oxymetazoline nasal sprays were commercially available.

DRUG

Placebo nasal spray

Placebo nasal spray has made by the local pharmaceutical company in thailand who commercially manufacture and sell 0.05% oxymetazoline nasal spray. The placebo contains the same ingredients as the drug except the active ingredient.

Trial Locations (1)

10700

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT01847131 - Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction | Biotech Hunter | Biotech Hunter